Developmental Malformations
Rhombencephalosynapsis
Oct. 16, 2023
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Most tissues can synthesize myo-inositol following phosphorylation of D-glucose to glucose-6-phosphate with subsequent synthesis of myo-inositol-1-phosphate, which then forms free myo-inositol after dephosphorylation. Myo-inositol can be incorporated into the phosphoinositides cycle, further catabolized to D-glucuronate for renal excretion or converted back to glucose-6-phosphate after a series of enzymatic reactions. Myo-inositol can also be converted to D-chiro-inositol by the enzymatic action of an epimerase. (Source: D’Souza SW, Copp AJ, Greene ND, Glazier JD. Maternal inositol status and neural tube defects: a role for the human yolk sac in embryonic inositol delivery? Adv Nutr 2021;12[1]:212-22. Creative Commons Attribution [CC BY 4.0] license, creativecommons.org/licenses/by/4.0.)